| Patent | Date |
|---|
Novel Theranostic Agents For Psma Positive Cancers
App 20220305149 - PILLARSETTY; Naga Vara Kishore ; et al. | 2022-09-29 |
Multimodal silica-based nanoparticles
Grant 11,419,955 - Bradbury , et al. August 23, 2 | 2022-08-23 |
Bone Marrow-, Reticuloendothelial System-, And/or Lymph Node-targeted Radiolabeled Liposomes And Methods Of Their Diagnostic And Therapeutic Use
App 20220023450 - Pillarsetty; Naga Vara Kishore ; et al. | 2022-01-27 |
Small-molecule Hsp90 Inhibitors
App 20210323965 - Chiosis; Gabriela ; et al. | 2021-10-21 |
Dota-hapten Compositions For Anti-dota/anti-tumor Antigen Bispecific Antibody Pretargeted Radioimmunotherapy
App 20210145988 - CHEAL; Sarah M. ; et al. | 2021-05-20 |
Uses Of Labeled Hsp90 Inhibitors
App 20210138091 - Chiosis; Gabriela ; et al. | 2021-05-13 |
Anti- Polysialic Acid Antibodies And Uses Thereof
App 20210047436 - WANG; Linlin ; et al. | 2021-02-18 |
Small-molecule Hsp90 Inhibitors
App 20200385389 - Chiosis; Gabriela ; et al. | 2020-12-10 |
Multimodal Silica-based Nanoparticles
App 20200376149 - Bradbury; Michelle S. ; et al. | 2020-12-03 |
Systems and methods for determining optimum patient-specific antibody dose for tumor targeting
Grant 10,806,808 - Zanzonico , et al. October 20, 2 | 2020-10-20 |
Small-molecule HSP90 inhibitors
Grant 10,676,476 - Chiosis , et al. | 2020-06-09 |
Multimodal silica-based nanoparticles
Grant 10,548,998 - Bradbury , et al. Fe | 2020-02-04 |
Fluorescent silica-based nanoparticles
Grant 10,548,997 - Bradbury , et al. Fe | 2020-02-04 |
Bone Marrow-, Reticuloendothelial System-, And/or Lymph Node-targeted Radiolabeled Liposomes And Methods Of Their Diagnostic And
App 20190298853 - Pillarsetty; Naga Vara Kishore ; et al. | 2019-10-03 |
Small-molecule HSP90 inhibitors
Grant 10,167,285 - Chiosis , et al. J | 2019-01-01 |
Multimodal Silica-based Nanoparticles
App 20180326103 - Bradbury; Michelle S. ; et al. | 2018-11-15 |
Multimodal silica-based nanoparticles
Grant 10,039,847 - Bradbury , et al. August 7, 2 | 2018-08-07 |
Multimodal silica-based nanoparticles
Grant 9,999,694 - Bradbury , et al. June 19, 2 | 2018-06-19 |
Systems And Methods For Determining Optimum Patient-specific Antibody Dose For Tumor Targeting
App 20180133350 - Zanzonico; Pat B. ; et al. | 2018-05-17 |
Multimodal Silica-based Nanoparticles
App 20180093000 - Bradbury; Michelle S. ; et al. | 2018-04-05 |
Small-molecule Hsp90 Inhibitors
App 20170342073 - Chiosis; Gabriela ; et al. | 2017-11-30 |
Fluorescent Silica-based Nanoparticles
App 20170239378 - Bradbury; Michelle S. ; et al. | 2017-08-24 |
Uses Of Labeled Hsp90 Inhibitors
App 20140294725 - Chiosis; Gabriela ; et al. | 2014-10-02 |
Method For Diagnosing Or Treating Tumors Using Sphingomyelin Containing Liposomes
App 20140205543 - Penate-Medina; Oula ; et al. | 2014-07-24 |
Small-Molecule HSP90 Inhibitors
App 20110104054 - Chiosis; Gabriela ; et al. | 2011-05-05 |
Fluorine-18 derivatives of dasatinib and uses thereof
App 20100226853 - Veach; Darren R. ; et al. | 2010-09-09 |
Single Chain Fv constructs of anti-ganglioside GD2 antibodies
App 20030147808 - Cheung, Nai-Kong V. ; et al. | 2003-08-07 |
Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
Grant 6,451,995 - Cheung , et al. September 17, 2 | 2002-09-17 |
Synthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5.alpha.-epoxy 6.beta.-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT)
Grant 4,775,759 - Rice , et al. October 4, 1 | 1988-10-04 |
| 